MétaCan
Menu
Back to cohort
Record W2588103380 · doi:10.1093/ofid/ofw172.14

Is Routine Therapeutic Drug Monitoring of Antiretroviral Agents Warranted in Human Immunodeficiency Virus-Infected Children?

2016· article· en· W2588103380 on OpenAlexaff
Jennifer Tam, Elaine Lau, Cheryl Arneson, Georgina Macdougall, Debra Louch, Stanley Read, Ari Bitnun

Bibliographic record

VenueOpen Forum Infectious Diseases · 2016
Typearticle
Languageen
FieldMedicine
TopicHIV/AIDS drug development and treatment
Canadian institutionsHospital for Sick Children
Fundersnot available
KeywordsMedicineHuman immunodeficiency virus (HIV)DrugIntensive care medicineVirologyAntiretroviral drugAntiretroviral therapyImmunologyViral loadPharmacology

Abstract

fetched live from OpenAlex

Background. There have been no studies directly assessing the utility of therapeutic drug monitoring (TDM) in the pediatric human immunodeficiency virus (HIV) population. Current US Department of Health and Human Services (DHHS) guidelines do not recommend routine TDM. Routine TDM was implemented on a trial basis in the HIV Clinic at the Hospital for Sick Children in March 2014. The purpose of this project was to assess the utility of this strategy. Methods. This was a prospective observational study of routine TDM for protease inhibitors (PIs), nonnucleoside reverse transcriptase inhibitors (NNRTIs), and integrase inhibitors (IIs) in combination antiretroviral therapy (cART)-treated HIV-infected children. Voluntary informed consent was required. Outcome measures included the proportion of serum antiretroviral medication (ARV) levels in the therapeutic range and correlation of levels with virologic control, adherence, and toxicity. Results. Forty-eight of 64 cART-treated children in the clinic were recruited (75%). Their median age, viral load (VL), and CD4 percentage were 13 (3–18) years, <40 (<40–124) copies/mL, and 37.4% (8.4–47.9%), respectively; 45.8% were female. Viral load was <40 copies/mL in 91.7%. Adherence was assessed as excellent (>95%) in 95.8%. Fifty baseline trough serum levels were taken, including 19 (38%) for PIs, 27 (54%) for NNRTIs, and 4 (8%) for IIs. Sixty-eight percent (n = 34) of levels were within the therapeutic range, 10% (n = 5) were subtherapeutic, and 22% (n = 11) were supratherapeutic. The highest proportion of therapeutic levels were within the NNRTI class (77.8%) followed by PIs (52.6%) and IIs (50%) (P = 0.047). There was no statistically significant correlation between serum ARV levels and demographic data, VL, CD4%, adverse-event scores, or adherence. Only 1 dose adjustment was made for subtherapeutic raltegravir levels due to a presumed interaction with ritonavir. Conclusion. This study does not support routine use of TDM in generally healthy, well controlled cART-treated HIV-infected children, which is consistent with current DHHS guidelines. A more targeted strategy, such as when adherence is questioned or when there are suspected drug interactions, may be more appropriate. Disclosures. All authors: No reported disclosures.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.024
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.023

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.024
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.001
Science and technology studies0.0010.001
Scholarly communication0.0010.001
Open science0.0010.000
Research integrity0.0010.002
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.015
GPT teacher head0.300
Teacher spread0.285 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2016
Admission routes1
Has abstractyes

Explore more

Same venueOpen Forum Infectious DiseasesSame topicHIV/AIDS drug development and treatmentFrench-language works237,207